Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
### Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to delay absorption and reduce gastric irritation.
### Primary Indications
* **Analgesia:** Mild to moderate pain.
* **Anti-inflammatory:** Rheumatic diseases, osteoarthritis, rheumatoid arthritis.
* **Antipyresis:** Fever reduction.
* **Cardiovascular Protection:** Primary and secondary prevention of cardiovascular events (e.g., myocardial infarction, stroke) at low doses.
### Adult Dosing
* **Analgesia/Antipyresis:** 325 mg to 650 mg orally every 4 to 6 hours as needed. Maximum dose: 4000 mg per day.
* **Anti-inflammatory:** 2.6 g to 5.4 g per day, divided into 3 or 4 doses.
* **Cardiovascular Protection:**
* Primary prevention: 75 mg to 100 mg orally daily.
* Secondary prevention: 75 mg to 325 mg orally daily.
### Pediatric Dosing
Aspirin is **generally not recommended for children and teenagers** due to the risk of Reye's syndrome, a rare but serious condition. In specific circumstances (e.g., Kawasaki disease), dosing is determined by pediatric rheumatology or infectious disease specialists and is typically weight-based.
### Dose Adjustments
* **Renal Impairment:** Use with caution; dose reduction may be necessary in severe impairment.
* **Hepatic Impairment:** Use with caution.
### Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or tartrazine.
* History of aspirin-induced asthma, urticaria, or allergic-type reactions.
* Children and teenagers with viral infections (risk of Reye's syndrome).
* Active peptic ulceration or gastrointestinal bleeding.
* Severe hepatic or renal impairment.
* Severe heart failure.
* Hemophilia, thrombocytopenia, or other bleeding disorders.
### Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding time, bruising, epistaxis.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, hearing loss (especially at higher doses).
### Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs:** Additive gastrointestinal and bleeding risks.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Methotrexate:** Increased methotrexate toxicity.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** May decrease antihypertensive efficacy and increase risk of renal impairment.
* **Valproic acid:** Increased free valproic acid concentration.
* **Uricosuric agents (e.g., probenecid):** Decreased efficacy.
### Monitoring
* Signs and symptoms of gastrointestinal bleeding (melena, hematemesis, abdominal pain).
* Bleeding and bruising.
* Renal and hepatic function, especially with chronic use or in patients with pre-existing impairment.
* Tinnitus or hearing changes (may indicate toxicity).
### Clinical Pearls
* The enteric coating delays absorption and reduces immediate gastric irritation but does not eliminate the risk of GI side effects with chronic use.
* Do not crush or chew enteric-coated tablets.
* Discontinue use at least 5-7 days before surgery due to prolonged bleeding time.
* Consider proton pump inhibitors (PPIs) or misoprostol for patients at high risk of GI complications, especially at higher aspirin doses.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and local protocols for complete and up-to-date guidance.*
